Search Results
Found 2 results
510(k) Data Aggregation
(266 days)
CardioGard Emboli Protection Cannula
The CardioGard Emboli Protection Cannula combines the function of a standard arterial cannula with an added suction mechanism to capture debris that may result from cardiac surgery.
The CardioGard Emboli Protection Cannula is intended for perfusion of the ascending aorta during short term (
The CardioGard Emboli Protection Cannula (CardioGard Cannula) is a sterile, single-use, disposable double lumen arterial cannula. The CardioGard Cannula features a tip configuration that diffuses oxygenated blood from the heart-lung machine into the ascending aorta through the Cannula Outlet, while also aspirating blood and embolic matter through the Suction Lumen Inlet. The flow rates through the two cannula lumens are carefully controlled so that emboli are suctioned back to the heart-lung machine for filtration while still enabling sufficient blood flow to the patient.
This document describes a 510(k) premarket notification for the CardioGard Emboli Protection Cannula, assessing its substantial equivalence to a previously cleared device (K141465). The focus of the changes in the modified device is to reduce device bulk and improve ease of use, while maintaining safety and effectiveness.
Here's an analysis of the acceptance criteria and supporting studies:
-
Table of Acceptance Criteria and Reported Device Performance:
The document provides a comparative table (starting on page 5) outlining various design and performance characteristics between the "Cleared Device" (predicate) and the "Modified Device" (current submission). It doesn't explicitly state "acceptance criteria" for each row, but rather describes how the modified device compares to the predicate and notes whether they are "Same" or "Substantially equivalent" with a discussion of differences.
Parameter Acceptance Criteria (Implied) Reported Device Performance (Modified Device) Intended Use Same as predicate. Same as predicate. Use Duration Same as predicate (≤ 6 hours). Same as predicate (≤ 6 hours). Cannula Design Substantially equivalent to predicate, aiming for reduced bulk and improved ease of use. Two lumen, curved tip with two ports (aortic perfusion, embolic particle suction). Suction tube angles 90° to reduce cannula profile. Tip Angle 30° to 60° (same as predicate). 30° to 60° (substantially equivalent). Tip Shape Substantially equivalent to predicate, with features for ease of insertion and reduced back pressure. Angled and tapered with dispersion side holes. Tip tapered for ease of insertion, dispersion side holes added to reduce back pressure. Flange Redesigned for ease of suturing. Redesigned flange to facilitate suturing in place. Dimensions Substantially equivalent to predicate, with slight modifications to reduce bulk and improve ease of use. Tip Size: Starts at 24Fr, ends at 22Fr. Main tube: diameter: 5/16" tapered to 3/8", length: 19–21 cm. Suction tube: diameter: 3/16" tapered to 1/4", length: 18–19 cm. (Slight modifications from predicate for bulk reduction/ease of use). Connectors Addition of connector to suction tube for user convenience. Connectors on both main and suction tubes (added connector to suction tube for user convenience). Caps Color-coded caps on both tubes for user convenience. Caps on both tubes: red for main tube and yellow for suction tube (color-coded for user convenience). Main (perfusion) Flow Rate 1 - 6 L/min (same as predicate). 1 - 6 L/min (same). Suction Flow Rate 0 - 1.0 L/min (reduced maximum from predicate to ensure 5 L net forward flow). 0 - 1.0 L/min (substantially equivalent, max suction flow rate reduced to provide for 5 L net forward flow). Pressure Drop Within accepted range for aortic cannulas (substantially equivalent to predicate). Pressure drop for both devices within accepted range for aortic cannulas (graphical comparison indicates substantial equivalence). Biological Safety - Materials Biocompatibility confirmed in accordance with ISO 10993. Tip: Polycarbonate (changed from PVC). Tubes: PVC (Plastisol) with stainless steel inner spring (same). Connectors: Polycarbonate (changed from ABS plastic). Caps: Polyethylene with PVC (Plastisol) outer cover (changed from Polyethylene). Biocompatibility confirmed. Sterilization EtO sterilized, single-use, disposable, non-pyrogenic (same method and characteristics). EtO sterilized, single-use, disposable, non-pyrogenic (same). EtO Sterilization Validation SAL 10^-6^ using overkill method, half-cycle technique (EN ISO 11135-1:2008), EO/ECH residuals for endotoxins, USP for pyrogenicity, ISO 10993-1:2009 for biocompatibility). - Direct comparison to a legally marketed predicate device: For dynamic hemolysis and functional performance (embolic particle capture), the performance of the modified device was compared against the predicate device (K141465) or another commercially available arterial cannula (Medtronic Select 3D II).
- Pre-defined acceptance criteria: For packaging and device integrity, explicit acceptance criteria were used.
-
The sample size for the training set:
Not applicable. This is a physical medical device, not an AI/machine learning system that requires a "training set."
-
How the ground truth for the training set was established:
Not applicable, as no training set was used.
Ask a specific question about this device
(220 days)
CARDIOGARD EMBOLI PROTECTION CANNULA
The CardioGard Emboli Protection Cannula combines the function of a standard arterial cannula with an added suction mechanism to capture debris that may result from cardiac surgery. The CardioGard Emboli Protection Cannula is intended for perfusion of the ascending aorta during short term (≤ 6 hours) cardiopulmonary bypass (CPB) procedures. The CardioGard suction lumen is intended for the removal of particulate emboli during surgical procedures that require CPB.
The CardioGard Emboli Protection Cannula, shown below, is a disposable 24 French double lumen arterial cannula. The cannula functions to deliver oxygenated blood to the heart during procedures requiring cardiopulmonary bypass (CPB), while at the same time suctioning blood and embolic matter away from the surgical field. The arterial cannula is inserted centrally in the ascending aorta. The CardioGard Emboli Protection Cannula features a tip configuration which diffuses oxygenated blood from the heart-lung machine to the ascending aorta through the Cannula Outlet, while also aspirating blood and embolic matter through the Suction Lumen Inlet. The flow rates through the two cannula lumens are carefully controlled so that emboli are suctioned back to the CPB machine for filtration while still enabling sufficient blood flow into the aorta.
Based on the provided text, the device being discussed is the CardioGard Emboli Protection Cannula. It's important to note that this document is a 510(k) summary for a medical device and not a submission for an AI/ML-based device. Therefore, the questions about "AI vs without AI assistance," "standalone algorithm performance," and "ground truth establishment for training set" are not directly applicable in the context of this device's approval process as described.
However, I can extract information related to the device's acceptance criteria and the study that proves it meets them, adapting the requested structure to fit the available details.
The core of the "acceptance criteria" here is "substantial equivalence" to a predicate device, demonstrated through various non-clinical and clinical tests.
Acceptance Criteria and Device Performance for CardioGard Emboli Protection Cannula
The acceptance criteria for the CardioGard Emboli Protection Cannula are primarily demonstrated through its substantial equivalence (safety and effectiveness) to predicate devices, namely the Embol-X Access Device/Aortic Cannula and the Embol-X Intra-Aortic Filter. This equivalence is shown through comparative testing against specific performance attributes.
1. Table of Acceptance Criteria and Reported Device Performance
Note: The document describes "acceptance criteria" primarily through comparative performance to a predicate device and meeting pre-defined thresholds in various non-clinical tests. "Reported device performance" here refers to the outcomes of these tests. As this is not an AI/ML context, metrics like sensitivity/specificity are not applicable.
Acceptance Criteria (Demonstrated Substantial Equivalence / Performance Threshold) | Reported Device Performance (CardioGard Emboli Protection Cannula) |
---|---|
Intended Use Equivalence: Combines arterial perfusion and embolic particle capture during CPB. | Functionally equivalent to the combined Embol-X Aortic Cannula and Intra-Aortic Filter. Intended for perfusion of ascending aorta during short term (≤ 6 hours) CPB procedures, with the suction lumen intended for removal of particulate emboli. |
Use Duration Equivalence: Capable of use for the entire duration of CPB surgery (≤ 6 hours). | Can be used for the entire duration of CPB surgery (≤ 6 hours), similar to the Embol-X Cannula. (This is a differentiating factor from the Embol-X filter, which has a 60-minute limit). |
Design Similarity & Functionality: Curved tip with two ports (perfusion + embolic particle removal). | Two lumen, curved tip with two ports: one for aortic perfusion, one for suction of embolic particles. Main difference is the method of embolic particle removal (suction vs. filter). In vitro side-by-side comparison testing demonstrated substantial equivalence of these two methods. |
Dimensions Equivalence: Similar tip size, length, and tube diameters. | Tip Size: 24Fr, Length: 30cm, Main tube diameter: 3/8", Suction tube diameter: 1/4". These are similar to the predicate Embol-X Access Device/Aortic Cannula (Tip Size: 24Fr; 20 Fr effective flow, Length: 28 cm, Main tube diameter: 3/8"). |
Pressure Drop Performance: Acceptable pressure drop for arterial perfusion. | Demonstrated smaller (better) pressure drop compared to the predicate Embol-X Cannula at all measured flow rates (3, 4, 5, and 6 l/min) in in vitro side-by-side comparison testing. |
Back Pressure Equivalence: Acceptable back pressure performance. | Demonstrated substantially equivalent back pressure compared to the predicate Embol-X Cannula in side-by-side comparison testing. |
Hemolysis Potential Equivalence: Acceptable levels of blood damage. | Demonstrated substantially equivalent hemolysis potential compared to the Embol-X Cannula and Filter under worst-case conditions (highest flow rates, simulating 6-hour CPB). |
Embolic Particle Capture Efficacy: Effective removal of embolic particles. | Demonstrated substantially higher embolic particle capture compared to the Embol-X Cannula and Filter under test conditions simulating a 6-hour CPB procedure. Additionally, an animal study showed capture of a mean of 77% of injected osseous embolic particles. |
Biocompatibility: Materials are safe for contact with blood. | Materials (PVC, Nirosta, ABS) are commonly used in medical devices and confirmed biocompatible according to ISO 10993-1:2009 for externally communicating devices in contact with circulating blood for limited ( |
Ask a specific question about this device
Page 1 of 1